Initiated in 2016, the project for establishing a Medicines Verification System reached its most important milestone in February 2019, when all operators in the pharmaceutical sector in Finland adopted the system. QA Manager Teijo Yrjönen of the Finnish Medicines Verification Organisation FiMVO is pleased with the situation in Finland. The system was adopted by a very wide range of operators.
- The entire Finnish pharmaceutical supply chain – the pharmaceutical industry, pharmaceutical wholesalers, pharmacies and hospital pharmacies – participated actively in the implementation of the Medicines Verification System. Many IT system suppliers also participated in the project. All in all, the project was a highly complex undertaking with a lot of different dependencies. The project participants collaborated very closely and actively, and gave a lot of feedback and development suggestions. I would like to thank all participants for their great co-operation, says Yrjönen.
Yrjönen joined the project in August 2017. Initially, he worked as a part-time consultant for the project, but six months ago, he became a full-time employee of FiMVO.
- FiMVO is responsible for building and administering the Finnish Medicines Verification System. Our task is to ensure that the system performs its statutory duties and that all operators in the pharmaceutical supply chain can start using it. Each operator has their own needs regarding the system, so we act as coordinators to ensure that the system meets all parties’ needs as well as possible, he says.
Although the deployment of the system has progressed well for the most part, there is still work to be done both in the system and in operating procedures. We are currently in a so-called soft deployment phase during which the users practice the new operating procedures and give feedback and development suggestions.
- At present, we are monitoring the situation and are collecting feedback from the end users, pharmaceutical companies and IT suppliers. We have received both praise and constructive criticism. In particular, we have been praised for our proactive approach in offering help and guidance for managing various situations.
The next update to the Finnish Medicines Verification System will take place in June. The update fixes some bugs and enhances the reporting features. The system will be updated about twice a year from now on.
On the European level, the Medicines Verification System is administered by EMVO (European Medicines Verification Organisation). Its members consist of the federations of the European pharmaceutical industry, pharmaceutical wholesalers, pharmacies and hospital pharmacies. FiMVO also participates actively with other national medicines verification organisations in the collaboration between EMVO and its stakeholders.
- Discussions on the Medicines Verification System continue on both the national and EU-level. We are currently evaluating the performance of processes and procedures and are standardising the use of the system. Furthermore, we are discussing the interpretation of the legislation on medicines verification concerning some details. The standardisation of the operations will probably continue far into 2020.
Finnish Medicines Verification Organisation FiMVO in brief
FiMVO is a non-profit company that is responsible for building and administering the Finnish Medicines Verification System. FiMVO was established in December 2016. The company is owned by Pharma Industry Finland (PIF), Orion Corporation, Rinnakkaislääketeollisuus Ry (an association for the generics industry), Suomen Lääkerinnakkaistuojat ry (an association for generics importers), the Association of Finnish Pharmacies and Lääke- ja terveyshuolto ry (an association for pharmaceutical distributors and health care service providers). For more information, please see >